Skip to main content
OpenTrials
Completed

NCT Number: NCT01080313

Head and Neck Cancer Registry (LORHAN)

The primary objective of this study is to describe, in detail, patterns of care for head and neck carcinoma patient

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Head and Neck Cancer Head and Neck Neoplasms Neoplasms Neoplasms by Site

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Mednet Solutions

Minnetonka, Minnesota, 55305, United States

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Pathologically (histologically or cytologically) confirmed new diagnosis of carcinoma involving the oral cavity, oropharynx, nasopharynx, hypopharynx, larynx, or neck node metastasis from unknown origin
  • Scheduled to receive radiotherapy and/or drug therapy including chemotherapy, biologic therapy and targeted therapy
  • Written informed consent

Exclusion criteria

  • Registry participation does not exclude participation in clinical trials.
  • Patients scheduled to receive or who have received surgery are eligible for Registry participation as long as they are also scheduled to receive medical therapy.

Treatment and study plan

Therapy for head and neck cancer

Other

radiotherapy and/or drug therapy including chemotherapy, biologic therapy and targeted therapy

Primary outcomes

  1. Patterns of care for head and neck cancer

    Time frame: up to 10 years

Secondary outcomes

  1. Overall survival by treatment regimen

    Time frame: study entry to death from any cause or to end of study

  2. Determine the incidence and severity of major dose-limiting and other important treatment toxicities

    Time frame: up to 10 years

  3. Identify supportive care received for managing nutrition, pain, nausea and other complications

    Time frame: up to 10 years

  4. tumor control by treatment regimen

    Time frame: study entry to progressive disease

Sponsors and collaborators

Lead sponsor

Eli Lilly and Company

Industry

Registry information

Official study title

Prospective, Longitudinal, Multi-Center, Descriptive Registry of Patients Receiving Therapy Other Than Surgical Resection Alone for Newly Diagnosed Head and Neck Cancer

Acronym: LORHAN

Important dates

Study start
2005
Primary completion
2011
Study completion
2011
First posted
Mar 4, 2010
Registry last updated
Feb 13, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.